- Home
- TIMB vs ZNTL Comparison
TIMB vs ZNTL Comparison
Compare TIMB & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIMB
- ZNTL
- Stock Information
- Founded
- TIMB 1998
- ZNTL 2014
- Country
- TIMB Brazil
- ZNTL United States
- Employees
- TIMB N/A
- ZNTL N/A
- Industry
- TIMB Telecommunications Equipment
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- TIMB Telecommunications
- ZNTL Health Care
- Exchange
- TIMB Nasdaq
- ZNTL Nasdaq
- Market Cap
- TIMB 94.1M
- ZNTL 105.8M
- IPO Year
- TIMB 1998
- ZNTL 2020
- Fundamental
- Price
- TIMB $20.94
- ZNTL $1.99
- Analyst Decision
- TIMB Hold
- ZNTL Buy
- Analyst Count
- TIMB 4
- ZNTL 7
- Target Price
- TIMB $20.17
- ZNTL $8.46
- AVG Volume (30 Days)
- TIMB 384.5K
- ZNTL 784.9K
- Earning Date
- TIMB 07-30-2025
- ZNTL 08-06-2025
- Dividend Yield
- TIMB 6.35%
- ZNTL N/A
- EPS Growth
- TIMB 16.41
- ZNTL N/A
- EPS
- TIMB 0.27
- ZNTL N/A
- Revenue
- TIMB $4,779,664,328.00
- ZNTL $26,865,000.00
- Revenue This Year
- TIMB $8.16
- ZNTL N/A
- Revenue Next Year
- TIMB $5.27
- ZNTL N/A
- P/E Ratio
- TIMB $15.20
- ZNTL N/A
- Revenue Growth
- TIMB 5.32
- ZNTL N/A
- 52 Week Low
- TIMB $11.32
- ZNTL $1.01
- 52 Week High
- TIMB $21.08
- ZNTL $5.44
- Technical
- Relative Strength Index (RSI)
- TIMB 66.41
- ZNTL 78.59
- Support Level
- TIMB $20.28
- ZNTL $1.55
- Resistance Level
- TIMB $20.60
- ZNTL $1.70
- Average True Range (ATR)
- TIMB 0.32
- ZNTL 0.12
- MACD
- TIMB 0.05
- ZNTL 0.05
- Stochastic Oscillator
- TIMB 91.89
- ZNTL 91.43
About TIMB TIM S.A. (Each representing 5)
TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.